If you are wondering whether GSK is still attractively priced after its recent run, you are not alone and this article is for ...
GSK GSK stock has risen 18.6% in the past three months. The price recovery was backed by strong third-quarter results, wherein the British drugmaker beat estimates for both earnings and sales. The ...
On 24 February 2026, GSK plc repurchased 477,000 of its 31¼ pence ordinary shares on the London Stock Exchange and Cboe Europe venues at prices between 2,175p and 2,217p, with a volume-weighted ...
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate ...
The average one-year price target for GSK (OTCPK:GLAXF) has been revised to $23.15 / share. This is an increase of 11.52% from the prior estimate of $20.76 dated November 9, 2025. The price target is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results